• Suma Krishnan, President, R&D, sold 27,000 Krystal Biotech common shares on June 4.
• Sales priced from USD 300.75 to USD 311.65 per share.
• Direct holdings fell to 1,378,155 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Krystal Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001298711-26-000006), on June 05, 2026, and is solely responsible for the information contained therein.